Anne Wojcicki Quotes

Drug discovery is terribly expensive, just to find out how one drug could or could not work and all its side effects.

All I ever promised was that I was sure I could develop a new pharmacological agent which might answer a physiological question. Any utility would be implicit in that answer.

Now, what tends to happen is that the stories get hyped. And the medicines are not quite as revolutionary and as dramatic as they seem to be. But, certainly, various phases of this problem are being attacked by the pharmaceutical companies.

Analytical pharmacology has got an important and exciting future.

I want to make a drug. I want the science to be more than imaginary, where I think, 'We're learning these fundamental principles, blah, blah, blah, blah, blah.' I think we are doing that, but I want to do something really practical. I want to actually, in my lifetime, help people.

The United States has an active pharmaceutical industry that has brought huge benefits to the U.S. public. Most Americans, who benefit from these advances, have little understanding of how difficult it is to create an important new medical therapy and make it available to improve public health.

There is probably a promising drug candidate that has already been discovered for the treatment of Down syndrome that is sitting on the shelf of some drug company.

The problem we are trying to solve is that of drugs that would have never seen the light of day for reasons that have nothing to do with the inherent properties of drug candidates themselves and more to do with bureaucratic institutions within which they often sit.

To start with, pharma was an industry based on innovation, drug discovery.

There's always going to be the need for new medications, better medications.

In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.

I keep encouraging the pharmaceutical companies to put more money into R&D.

Perhaps the most useful lesson which has come out of the work on penicillin has been the demonstration that success in this field depends on the development and coordinated use of technical methods.

Pharmacology is benefited by the prepared mind. You need to know what you are looking for.

Even then, Vanderbilt was the premiere place for clinical pharmacology.

Biopharmaceutical research and development efforts have achieved dramatic improvements in global health and longevity, and we are committed to continuing our quest.

Once an effective drug is approved to treat a deadly condition, introducing a second drug to treat the same disease can be hard. It's tough to recruit patients with a debilitating disease for a clinical trial when a proven medicine is already available.

It seems paradoxical that, as medical scientists make huge advances in discovering the mechanisms of common diseases, fewer and fewer innovative drugs are reaching the market.

I've heard drug experts say they believe if penicillin were discovered today, the FDA wouldn't license it.

On the third stage is used for medicine, it is not known to the public.

The medicines of today are based upon thousands of years of knowledge accumulated from folklore, serendipity and scientific discovery. The new medicines of tomorrow will be based on the discoveries that are being made now, arising from basic research in laboratories around the world.

If you go to the FDA with a drug that's only meant to treat 50 people, and it's a 95 percent cure rate, you'll get your drug approved.

I'd like to focus on my life on creating new medicines for people who are suffering from rare disease.

If you sit in a position where decisions that you take would have a serious effect on people, you can't ignore a lot of experience around the world which says this drug has these negative effects.

The problem of chemotherapy of bacterial infections could be solved neither by the experimental medical research worker nor by the chemist alone, but only by the two together working in very close cooperation over many years.